Skip to main content
Clinical Trials/NCT03571581
NCT03571581
Completed
Not Applicable

Exploring the Role of Mindfulness Training in the Promotion of Medication Adherence in Heart Failure Outpatients.

The Miriam Hospital1 site in 1 country33 target enrollmentOctober 11, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Medication Non-adherence
Sponsor
The Miriam Hospital
Enrollment
33
Locations
1
Primary Endpoint
Retention Rate
Status
Completed
Last Updated
9 months ago

Overview

Brief Summary

This study investigated the feasibility and acceptability of a phone-delivered mindfulness intervention to improve medication adherence among outpatients with heart failure.

Detailed Description

This project seeked to study the role of mindfulness training (MT) in the promotion of medication adherence among patients with chronic heart failure (HF). A prospective pre/post design study was conducted among 50 stable outpatients with HF and sub-optimal self-reported medication adherence. MT sessions (one 30-min session/week over 8 weeks) were phone-delivered by qualified mindfulness instructors. Assessments were conducted at baseline, 3 months (end of the intervention) and 6 months since baseline. The primary outcomes were feasibility and acceptability. We hypothesized we would meet recruitment goals (n=50) within the study timeline, with \< 20% drop out rates by the end of the study and that \> 80% of participants would report high (=grade 5) enjoyment ratings on a self-report intervention enjoyment scale (range:1 to 5). Secondary outcomes were self-reported and objectively assessed medication adherence and functional capacity (a clinical marker of medication adherence. We hypothesized we would observe significant pre-post intervention improvements in medication adherence and functional capacity. Additional outcomes included possible mediators of intervention effect, i.e., cognitive function, mood, sleep quality, and interoceptive awareness.

Registry
clinicaltrials.gov
Start Date
October 11, 2018
End Date
August 31, 2020
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Elena Salmoirago-Blotcher

Research Scientist

The Miriam Hospital

Eligibility Criteria

Inclusion Criteria

  • Age \> = 18
  • Fluency in English language
  • A confirmed diagnosis of heart failure
  • Sub-optimal adherence to medications
  • Access to a telephone
  • Ability to understand and speak English

Exclusion Criteria

  • Unwillingness/inability to provide informed consent
  • New York Heart Association (NYHA) class IV heart failure or clinically unstable
  • Severe hearing impairment not allowing phone delivery
  • Severe depressive symptoms
  • Acute psychosis
  • Severe cognitive impairment
  • Recent hospitalization (\< 6 weeks)
  • Current (at least once a month) mind/body practice

Outcomes

Primary Outcomes

Retention Rate

Time Frame: 3 months, 6 months

Percentage of participants retained in the study (n enrolled/n retained X 100)

Intervention Acceptability

Time Frame: 3 months

Self-reported intervention enjoyment scale (1 = did not enjoy to 5 = enjoyed very much). Scores range from 1 to 5; higher scores mean a better outcome. The metric for this study was the percentage of participants indicating high intervention enjoyment (a score of 5).

Secondary Outcomes

  • Objectively-assessed Medication Adherence(baseline, 3 months, 6 months)
  • Self-reported Medication Adherence(baseline, 3 months, 6 months)
  • Functional Capacity(baseline, 3 months, 6 months)

Study Sites (1)

Loading locations...

Similar Trials